seekingalpha.com/article/...on-good-news-why-i-bought-that-dip
www.unither.com
www.unither.com
Top-News
UHTR
Beiträge:
5
Zugriffe: 6.774 / Heute: 2
Zugriffe: 6.774 / Heute: 2
|
Werbung
Entdecke die beliebtesten ETFs von Amundi
Lyxor Net Zero 2050 S&P World Climate PAB (DR) UCITS ETF Acc
Perf. 12M: +206,18%
Amundi ETF Leveraged MSCI USA Daily UCITS ETF - EUR (C/D)
Perf. 12M: +74,60%
Amundi Nasdaq-100 Daily (2x) Leveraged UCITS ETF - Acc
Perf. 12M: +66,25%
Amundi Russell 1000 Growth UCITS ETF - Acc
Perf. 12M: +38,69%
Amundi MSCI Wld Clim. Paris Align. PAB Umw. UCITS ETF DR C/D
Perf. 12M: +37,67%
www.unither.com
financials.morningstar.com/ratios/r.html?t=UTHR
markets.ft.com/research/Markets/Tearsheets/Forecasts?…
www.macroaxis.com/invest/compare/UTHR
Kurzporträt
Logo United Therapeutics Corpor
Develops pharmaceutical products
United Therapeutics Corp. operates as a biotechnology company, which focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.
The company operates in two business segments: Pharmaceuticals and Telemedicine.
Its primary product Remodulin is used for the treatment of pulmonary arterial hypertension and the company also develops glycol-biological antiviral agents for the treatment of infectious diseases, such as Hepatitis C. United Therapeutics was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
de.4-traders.com/UNITED-THERAPEUTICS-CORPO-11262/fundamentals/
financials.morningstar.com/ratios/r.html?t=UTHR
markets.ft.com/research/Markets/Tearsheets/Forecasts?…
www.macroaxis.com/invest/compare/UTHR
Kurzporträt
Logo United Therapeutics Corpor
Develops pharmaceutical products
United Therapeutics Corp. operates as a biotechnology company, which focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.
The company operates in two business segments: Pharmaceuticals and Telemedicine.
Its primary product Remodulin is used for the treatment of pulmonary arterial hypertension and the company also develops glycol-biological antiviral agents for the treatment of infectious diseases, such as Hepatitis C. United Therapeutics was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
de.4-traders.com/UNITED-THERAPEUTICS-CORPO-11262/fundamentals/
www.analystratings.com/articles/...a-buy-rating-from-wedbush/
www.analystratings.com/articles/...ed-its-third-buy-in-a-row/
- Dr. Reddy's kündigt die Einführung der Treprostinil Injektion an, einer therapeutischen äquivalenten generischen Version von Remodulin (Treprostinil) Injektion
www.sec.gov/Archives/edgar/data/1135951/...drr0473_ex99-1.htm
Remodulin ist UTHR's zweitstärkstes Produkt, gemessen am Umsatz von 500 Mio. $ in 2022
Es gibt keine neuen Beiträge.
Neueste Beiträge aus dem United Therapeutics Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
2 | 4 | UHTR | Tamakoschy | Vassago | 21.04.23 15:35 |
